Rocket


Overview
Financials
News + Filings
Key Docs
Ownership





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Erytech Pharma S.A. (ERYP)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15
   20-F20-F20-F
Revenues   [+]-26.6-15.6-7.8
            Revenue growth  70.5%98.6% 
Cost of goods sold  0.00.0-15.5
Gross profit  -26.6-15.67.6
            Gross margin  100.0%100.0%-97.2%
Selling, general and administrative   [+]10.66.87.7
EBITDA   [+]-36.6-22.0-15.3
            EBITDA margin  137.8%141.0%194.9%
Depreciation and amortization  0.50.40.3
EBIT   [+]-37.1-22.4-15.6
            EBIT margin  139.8%143.7%198.6%
Other income (expense), net  -3.20.50.6
Pre-tax income  -40.3-21.9-15.0
Income taxes  0.00.00.0
            Tax rate   0.0% 
Net income  -40.3-21.9-15.0
            Net margin  151.7%140.6%191.3%
   
Basic EPS   [+]($3.54)($2.74)($2.16)
Diluted EPS   [+]($3.54)($2.74)($2.16)
   
Shares outstanding (basic)   [+]11.48.07.0
Shares outstanding (diluted)   [+]11.48.07.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy